Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform


Out of Business LATEST DEAL TYPE

Provider of advanced tissue engineering for research applications intended to address the growing demand for reliable, cost-effective and quality test methods for product evaluation. The company's applications specialize in providing research and development, validation, manufacturing and commercialization of advanced human tissue models, enabling clients to reduce and replace animal experimentation, for both industrial safety and efficacy testing as well as medical research.

Ownership Status
Out of Business
Financing Status
Formerly Angel backed
Primary Industry
Primary Office
  • House of BioHealth
  • 29, Rue Henri Koch
  • Esch-sur-Alzette, L-4354
  • Luxembourg

+352 28 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Atera’s full profile, request a free trial.

Atera Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Aug-2019 00.000 Completed Out of Business
1. Angel (individual) 08-Mar-2016 00.000 00.000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Atera Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ReproCELL Formerly VC-backed Yokohama, Japan 000 000.00 00000000 000.00
000000000 00000000 Corporation Carlsbad, CA
00000000 Accelerator/Incubator Backed Toulouse, France 0 0000000000
0000000 Venture Capital-Backed Vancouver, Canada 0 00000 0000000000 0 00000
00000000 000000000 Private Equity-Backed Vancouver, Canada 0000 000.00 00000000. 00 000.00
To view this company’s complete list of competitors, request access »